Cutler Group LP I Bio, Inc. Put Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 Apr 14, 2022	SELL	$0.3 - $0.61 $2,760 - $5,612	-9,200 Reduced 87.62%	1,300 $1,000
Q4 2021 Jan 18, 2022	SELL	$0.55 - $1.04 $12,265 - $23,192	-22,300 Reduced 67.99%	10,500 $7,000
Q3 2021 Oct 26, 2021	SELL	$1.06 - $1.52 $8,374 - $12,008	-7,900 Reduced 19.41%	32,800 $10,000
Q2 2021 Jul 19, 2021	BUY	$1.22 - $1.65 $38,552 - $52,140	31,600 Added 347.25%	40,700 $11,000
Q1 2021 Apr 26, 2021	SELL	$1.18 - $2.62 $7,670 - $17,030	-6,500 Reduced 41.67%	9,100 $3,000
Q4 2020 Jan 21, 2021	BUY	$1.05 - $2.24 $11,025 - $23,520	10,500 Added 205.88%	15,600 $4,000
Q3 2020 Oct 27, 2020	BUY	$1.7 - $6.41 $8,670 - $32,691	5,100 New	5,100 $7,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.